Alana Hippensteele, Lead Editor

Results from 2 initial phase 3 studies evaluating an investigational 15-valent pneumococcal conjugate vaccine were recently released, assessing its immunogenicity, safety, and tolerability.

According to a recent study published in Gut, inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn disease, is associated with a more than doubled likelihood of developing dementia.

A recent study showed that long-term exposure to fine particulate outdoor air pollution is a key contributor to cardiovascular disease and death throughout the world, regardless of the income bracket of the various countries.

A recent qualitative study presented a potential explanation for why health system specialty pharmacies often find it difficult to partner with payers.

New contraceptive from Evofem Biosciences maintains acidic environment inhospitable to sperm.

A study presented at the Society of Gynecologic Oncology 2020 Annual Meeting on Women’s Cancer showed menstrual cups may provide a novel, less invasive, and more comfortable approach to the diagnosis of endometrial cancer.

A phase 2 clinical trial demonstrated that a 2-week course of teplizumab was able to delay the onset of clinical type 1 diabetes by 3 years compared with patients taking a placebo.

According to a new study by West Health and Gallup, 88% of US adults support the federal government directly negotiating the price of a COVID-19 treatment with a drug manufacturer upon its availability due to concerns regarding raised drug prices.

Giant Food has announced that all vaccinations recommended by the ACIP are once again available at its 153 in-store pharmacies across Virginia, Maryland, Delaware, and the District of Columbia.

According to a recent study presented at the ADA’s 80th Scientific Sessions, youth and young adults with type 1 diabetes (T1D) in the United States today have worse glycemic control than prior generations.

Treatment of recently diagnosed patients with type 1 diabetes (T1D) with anti-IL-21 and liraglutide for 54 weeks was found to be safe and resulted in sustained insulin secretion and lower insulin dose.

The results of the study demonstrated that dapagliflozin was able to reduce new-onset diabetes by 32%.

FDA officials based their approval on the review of data and evidence that demonstrated a close similarity between pegfilgrastim-apgf and its reference product.

According to a recent study, patients with type 2 diabetes mellitus (T2D), but not prediabetes, demonstrated poorer cognitive performance 3 to 6 months after a stroke.

A recent study in the UK that estimated the amount of life lost from type 1 and type 2 diabetes in the country’s population found that the loss amounted to approximately 6.4 million years of future life in the current population.

According to a recent study, diet can affect the outcome of chemotherapy due to microbes in the gut that can trigger changes in a patient’s response to drugs.

A recent study was able to identify the region of the brain where executive functioning takes place due to the brain of a unique patient with dys-executive syndrome.

According to a recent study, people with a higher risk of cardiovascular disease demonstrate an increase in cognitive decline, including a rise in the typical markers of Alzheimer disease.

There has been more attention been paid to the pulmonary complications of COVID-19, with less attention being paid to the cardiovascular complications that can result in death or impairment.

According to a recent study, olanzapine may help patients with advanced cancer manage symptoms unrelated to chemotherapy, such as nausea and vomiting.

The US Senate recently passed the Paycheck Protection Program Flexibility Act after its quick success in the House last week.

At the 2020 ASCO Annual Meeting, speaker Leslie R. Ellis, MD, MSHPEd, FACP, discussed the results of studies in a session looking into current research on leukemia, MDS, and allotransplant.

The presence of ongoing SHM or CSR in the context of CLL may support the functionality of DNA damage repair pathways, with potential relevance to therapeutic strategies.

According to a new survey released by the NCPA, COVID-19 is changing how local pharmacies do business across the country, and these changes may be for the long term.

At the 2020 American Society of Clinical Oncology Virtual Scientific Program, researchers presented a recent study that is the largest to date analyzing CLL treatment patterns among VHA patients between 2013 and 2018.

In 2017 alone, there was an estimated 785 fewer cancer deaths in states that adopted Medicaid expansion.

At 5 years follow up, the data showed that the OS for women on olaparib was 42.1%, while the placebo OS was 33.2%.

A new law approved in Minnesota this week expands pharmacists’ authority by allowing them to administer FDA-authorized COVID-19 or SARS-CoV-2 vaccines when they become available.

New York Governor Andrew Cuomo announced last week that New York will launch a COVID-19 testing pilot program with a goal of conducting 7000 tests per week.

A study released today demonstrated that tocilizumab has been shown to significantly improve survival outcomes for patients with COVID-19.